The FDA approved nivolumab with ipilimumab in adult and pediatric patients with CRC based on data from the phase 3 CHECKMATE-8HW trial.
Approval Alert | Nivolumab/Ipilimumab in Adult/Pediatric MSI-H or dMMR CRC
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Niraparib Regimen in BRCA2+ Metastatic CSPC
2
ASH 2025: The Top 10 Takeaways for Hematologic Oncology Care
3
Cognitive Function Improvements Highlighted With Acupuncture Use in Breast Cancer
4
The Battle Between MARIPOSA and FLAURA2 Regimens in NSCLC
5
